Date of announcement 2016/12/19
Time of announcement 22:39:14

Date of events 2016/12/19
To which item it meets paragraph 20
Statement
1.Name and nature of the subject matter (if preferred shares, the terms and conditions of issuance shall also be indicated, e.g.dividend yield):CDIB Venture Capital Corporation
2.Date of occurrence of the event:2016/12/19
3.Volume, unit price, and total monetary amount of the transaction:
Total monetary amount of the transaction：No more than NTD 1,500 million
4.Counterpart to the trade and its relationship to the Company (if the trading counterpart is a natural person and furthermore is not an actual related party of the Company, the name of the trading counterpart is not required to be disclosed):
Counterpart： CDIB Venture Capital Corporation
Its relationship to the Company：CDIB Venture Capital Corporation is 100% owned subsidiary of CDIB.
5.Where the counterpart to the trade is an actual related party, a public announcement shall also be made of the reason for choosing the related party as trading counterpart and the identity of the previous owner (including its relationship with the company and the trading counterpart), price of transfer, and date of acquisition:
To acquire new shares of CDIB Venture Capital Corporation
6.Where a person who owned the property within the past five years has been an actual related person of the company, a public announcement shall also include the dates and prices of acquisition and disposal by the related person and the person’s relationship to the company at those times:N/A
7.Matters related to the creditor's rights currently being disposed of (including types of collateral of the disposed creditor's rights; if the creditor's rights are creditor's rights toward a related person, the name of the related person and the book amount of the creditor's rights toward such related person currently being disposed of must also be announced):N/A
8.Anticipated profit or loss from the disposal (not applicable in cases of acquisition of securities) (where originally deferred, the status or recognition shall be stated and explained):N/A
9.Terms of delivery or payment (including payment period and monetary amount), restrictive covenants in the contract, and other important stipulations:
Payment will be delivered based on the consensus of transaction schedule
10.The manner in which the current transaction was decided, the reference basis for the decision on price, and the decision-making department:
The manner in which the current transaction was decided, the reference basis for the decision on price: To acquire new shares of CDIB Venture Capital Corporation, 100% owned shares of CDIB
The decision-making department：The transaction to be approved by the Board of CDIB
11.Current cumulative volume, amount, and shareholding percentage of holdings of the security being traded (including the current trade) and status of any restriction of rights (e.g.pledges):
Cumulative volume：1,072,790,915 shares
Cumulative amount：NTD 10,253 million
Shareholding percentage：100%
Status of any restriction of rights：N/A
12.Current ratio of long or short term securities investment (including the current trade) to the total assets and shareholder's equity as shown in the most recent financial statement and the operating capital as shown in the most recent financial statement:
Current ratio of long or short term securities investment (including the current trade) to the total assets in the most recent financial statement：74.25%
Current ratio of long or short term securities investment (including the current trade) to the shareholder's equity in the most recent financial statement：77.53%
The operating capital as shown in the most recent financial statement：N/A
13.Broker and broker's fee:N/A
14.Concrete purpose or use of the acquisition or disposal: For the needs of investment portfolio expansion
15.Net worth per share of the underlying securities acquired or disposed of:NTD 9.49
16.Do the directors have any objection to the present transaction?:NO
17.Has the CPA issued an opinion on the unreasonableness of the price of the current transaction?:N/A
18.Any other matters that need to be specified:
(1)CDIB invests no more than NTD 1,500 million to acquire new shares issued by CDIB Venture Capital Corporation, and then CDIB Venture Capital Corporation invests no more than RMB 299.35 million to acquire new shares issued by CDIB Venture Capital (Hong Kong) Corporation Limited in order for CDIB Venture Capital (Hong Kong) Corporation Limited to invest in CDIB Healthcare Private Equity ( Kunshan) Enterprise ( Limited Partnership )(tentative name).
(2)These transactions will not be processed until approved by the competent authority.